Comapring impact of Bles versus Curosurf in respiratory distress of preterm infants
Phase 2
- Conditions
- Respiratory Dystress Syndrome.Hyaline membrane diseaseP.22.0
- Registration Number
- IRCT2017021418994N3
- Lead Sponsor
- Vice Chancellor of Kerman University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 240
Inclusion Criteria
less than 34 weeks gestational age; Confirmed Respiratory Distress Syndrome
Exclusion Criteria
Confirmed Sepsis; Congenital heart diseases; Pulmonary hemorrhage; Congenital Pneumonia
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Oxygenic Index. Timepoint: Before and 12 hours after intervention. Method of measurement: According ABG and ventilator indices.;Ventilation period. Timepoint: Before and 12 hours after intervention. Method of measurement: Neonates medical records.;NCPAP period. Timepoint: before and 12 hours after Intervention. Method of measurement: Neonates medical records.;Hospitalization time. Timepoint: After Intervention. Method of measurement: Neonates medical records.
- Secondary Outcome Measures
Name Time Method Mortality rate. Timepoint: Before and 12 hours after intervention. Method of measurement: medical folder of neonates.
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms differentiate Bles from Curosurf in treating preterm respiratory distress syndrome (RDS)?
How does Bles compare to Curosurf in reducing mechanical ventilation duration for RDS in preterm neonates?
Which biomarkers correlate with improved surfactant efficacy in RDS infants treated with Bles or Curosurf?
What adverse events are associated with Bles versus Curosurf in neonatal RDS management and how are they managed?
Are there alternative surfactant therapies or combination approaches to Bles and Curosurf for RDS in preterm infants?